Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products globally. The company operates through four segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators used to assess sterilization and disinfection processes in pharmaceutical, medical device, and healthcare industries. The Clinical Genomics segment provides the MassARRAY genetic analysis system and related consumables for DNA analysis in inherited disease testing, pharmacogenetics, oncology, and infectious disease testing. The Biopharmaceutical Development segment includes automated systems like Gyrolab xPand and xPlore for protein analysis, as well as peptide synthesis instruments such as PurePep Chorus and Symphony. The Calibration Solutions segment provides quality control products for measuring and calibrating parameters in environmental monitoring, dialysis, gas flow, and torque testing.

Mesa Laboratories, Inc. is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol MLAB. The company's stock is traded in United States Dollars (USD). As a US-based company, its financial reporting and stock trading are conducted in USD, providing clarity for investors in the US and international markets.

Mesa Laboratories operates in the Technology sector and is classified under the Scientific & Technical Instruments industry. This industry includes companies that design, manufacture, and sell instruments and tools used for scientific research, analysis, and quality control. Mesa's focus on life sciences tools and quality control products aligns with this classification, as it provides advanced instrumentation and consumables for applications in pharmaceutical, medical device, healthcare, and clinical laboratory settings.

Mesa Laboratories, Inc. is headquartered in the United States and serves global markets. The company's products and services are used internationally across pharmaceutical, medical device, healthcare, dental, and clinical laboratory industries. Its global reach is evident from its description of operating globally, with segments providing testing and laboratory services to the dental and pharmaceutical industries, and genetic analysis tools used by clinical labs worldwide. The company's calibration solutions are applied in environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital settings.

Mesa Laboratories offers a diverse portfolio of products and services across its four segments. In Sterilization and Disinfection Control, it provides biological, chemical, and cleaning indicators to assess sterilization and disinfection effectiveness. The Clinical Genomics segment features the MassARRAY genetic analysis system, along with chips, panels, and chemical reagents for DNA analysis in various testing areas. The Biopharmaceutical Development segment includes automated systems like Gyrolab xPand and xPlore for protein analysis, Gyrolab Bioaffy consumable disks, kits, and Rexxip buffers, as well as PurePep Chorus and Symphony instruments for peptide synthesis and PurePep EasyClean products for peptide purification. The Calibration Solutions segment offers quality control products for measuring critical parameters such as temperature, pressure, and flow in applications like environmental monitoring, dialysis, and gas flow testing.